4 free views remaining today
Y-linked deafness 1
Description
Y-linked Deafness 1 (DFNY1)
Y-linked deafness 1, also known as DFNY1, is a genetic disorder that causes male-limited postlingual progressive sensorineural hearing loss of varying severity. This means that males with this condition experience a gradual decline in their ability to hear sounds, particularly after they have learned to speak (postlingual).
Characteristics:
- Male-only inheritance: DFNY1 is inherited solely through the Y chromosome and affects only males.
- Progressive hearing loss: The condition leads to a progressive decline in hearing abilities over time.
- Variable severity: The severity of hearing loss can vary significantly among affected individuals.
Causes and Molecular Basis
The molecular basis of DFNY1 is currently unknown. Research has mapped the disorder to the human Y chromosome, but further studies are needed to understand the underlying genetic mechanisms.
References:
- [1] A single Mendelian trait has been mapped to the human Y chromosome: Y-linked hearing impairment. The molecular basis of this disorder is unknown. (Source: 1)
- Y-linked deafness-1 (DFNY1) is a genetic disorder that causes male-limited postlingual progressive sensorineural hearing loss of varying severity, typically ... (Source: 3)
Note: The information provided above is based on the search results and context provided.
Additional Characteristics
- variable severity
- progressive hearing loss
- Y-linked deafness 1
- a genetic disorder that causes male-limited postlingual progressive sensorineural hearing loss of varying severity.
- male-only inheritance
Signs and Symptoms
Progressive Hearing Impairment
Y-linked deafness, type 1 is a rare genetic disorder that affects only males. The primary symptom of this condition is progressive hearing impairment, which means that the hearing loss worsens over time [11].
- Variable Onset: The age at which symptoms appear can vary among affected individuals.
- Lifelong and Progressing: Y-linked deafness, type 1 is a lifelong condition that continues to progress, leading to significant hearing loss.
It's essential to note that this condition exclusively affects males, as it is linked to the Y chromosome [5]. Early detection and evaluation are crucial to prevent further hearing loss and its negative effects on quality of life [13].
References: [11] - Symptoms: Progressive hearing impairment that occurs in all male members of a family. [5] - by Q Wang · 2013 · Cited by 42 — A single Mendelian trait has been mapped to the human Y chromosome: Y-linked hearing impairment. The molecular basis of this disorder is unknown. [13] - Hearing loss symptoms can vary from mild to severe. Sudden hearing loss is rare, but it can happen. Usually hearing loss develops gradually. Regardless of onset type or speed, any symptom of hearing loss should be evaluated to prevent further hearing loss and any negative effects on a person's quality of life.
Additional Symptoms
- Variable Onset
- Progressive hearing impairment
- Lifelong and Progressing
Diagnostic Tests
Diagnostic Tests for Y-linked Deafness 1
Y-linked deafness 1, also known as DFNY1 (MIM 400043), is a rare type of hereditary non-syndromic deafness that exclusively affects males. Establishing a diagnosis of this condition requires specific diagnostic tests.
- Physical exam: A healthcare provider may perform a physical examination to rule out other possible causes of hearing loss ([8]).
- Genetic testing: Genetic testing is the primary method for diagnosing Y-linked deafness 1. This involves looking for changes in genes associated with the condition, such as the DFNY1 gene ([5], [11]). The test may take 3-5 weeks to produce results ([6]).
- Full gene sequencing: In some cases, full gene sequencing may be performed to confirm the diagnosis of Y-linked deafness 1 ([11]).
It's essential to note that comprehensive genetic diagnosis for deafness has only recently been possible due to advances in genetic testing platforms and massively parallel sequencing (MPS) ([10]). Prior to the advent of MPS, standard DNA sequencing techniques such as Sanger sequencing were used.
References: [5] - Genetic or genomic testing looks for changes in genes known to cause deafness and be used to try and identify if your child's deafness has a genetic cause. [6] - This sample is sent to a diagnostic laboratory that looks for changes in genes that are most commonly associated with hearing loss. It may take 3-5 weeks to get the results. [8] - Diagnosis. Tests to diagnose hearing loss may include: Physical exam. A health care provider looks in your ear for possible causes of your hearing loss. [10] - Comprehensive genetic diagnosis for deafness has only recently been possible, an advance in clinical care linked to the development of novel genetic testing platforms for deafness based on massively parallel sequencing (MPS; reviewed in [2 ]). [11] - Deafness, Y-linked: Full gene sequencing. GTR Test ID Help Each Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. The format is GTR00000001.1, with a leading prefix 'GTR' followed by 8 digits, a period, then 1 or more digits representing the version. When a laboratory updates a ...
Treatment
Current Status of Drug Treatment for Y-linked Deafness, Type 1
Y-linked deafness, type 1 is a rare form of hereditary non-syndromic deafness characterized by progressive hearing loss that exclusively affects males. Unfortunately, there are no FDA-approved drugs specifically designed to treat this condition.
- Current treatment options: The primary methods for managing Y-linked deafness, type 1 are cochlear implants and hearing aids. These devices can help improve communication and quality of life for individuals with this condition (13).
- Regenerative treatments: Researchers have explored the possibility of regenerating hair cells using small molecule drugs like FX-322, which is currently in clinical trials. However, these treatments are not specifically designed to address Y-linked deafness, type 1.
- Gene therapy: Gene therapies, such as those targeting the OTOF gene, show promise for treating certain forms of hearing loss. However, more research is needed to determine their efficacy and safety for Y-linked deafness, type 1.
It's essential to note that Y-linked deafness, type 1 is a rare condition, and most information available is based on case studies or small-scale clinical trials. Further research is necessary to develop effective treatments for this specific form of hearing loss.
References: * [13] * [14]
Recommended Medications
- hearing aids
- cochlear implants
- FX-322 (small molecule drug)
- gene therapy targeting the OTOF gene
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Based on the provided context, it appears that Y-linked deafness, type 1 (DFNY1) is a rare form of hereditary non-syndromic deafness that affects males exclusively.
Causes and Characteristics
Y-linked deafness, type 1 is caused by mutations in the DFNY1 gene, which is located on the Y chromosome. This condition is characterized by progressive hearing loss that starts in childhood or adolescence and worsens over time [3].
Differential Diagnosis
The differential diagnosis for Y-linked deafness, type 1 includes other forms of hereditary non-syndromic deafness, such as autosomal dominant or recessive conditions. However, the key distinguishing feature of Y-linked deafness, type 1 is its exclusive inheritance pattern in males [4].
Other Considerations
It's worth noting that Y-linked deafness, type 1 is a rare condition, and other forms of hearing loss may be more common in clinical practice. Therefore, a thorough evaluation and diagnostic workup are necessary to rule out other potential causes of hearing loss.
References:
[3] by S ANGELI · 2012 · Cited by 168 — This article is a review of the genes and genetic disorders that affect hearing in humans and a few selected mouse models of deafness. [4] Thus, in early 2004 it was possible to write “pedigree analysis has yet to reveal a single Y-linked gene.” 5 Later that year, however, Y-linked hearing impairment (DFNY1, MIM 400043) was reported in a Chinese family 6 and remains the sole documented Mendelian disorder showing Y-linkage in humans.
Additional Differential Diagnoses
- Other forms of hereditary non-syndromic deafness
- Autosomal dominant or recessive conditions
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0111759
- core#notation
- DOID:0111759
- oboInOwl#hasDbXref
- MIM:400043
- IAO_0000115
- A Y-linked deafness characterized by male-limited postlingual progressive sensorineural hearing loss of variable severity, with onset in the first to third decades of life.
- oboInOwl#hasExactSynonym
- DFNY1
- rdf-schema#label
- Y-linked deafness 1
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_0111757
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_6079
- owl#annotatedSource
- t383867
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.